门静脉高压与肝硬化(英文)(Portal Hypertension & Cirrhosis)

门静脉高压与肝硬化(英文)(Portal Hypertension & Cirrhosis) 知网目次万方目次维普目次

  • 国级普刊
基本信息
  • 主管单位:

    中国科学技术协会

  • 主办单位:

    中华医学会

  • 国际刊号:

    2770-5838;EISSN 2770-5846

  • 国内刊号:

    10-1983/R5

  • 学科分类:

    内科学

  • 字数:

    4000-22000

  • 有无基金:

    /有基金 100.0%

  • 周期:

    CN外文-季刊

  • 特殊属性:

    外文期刊

联系信息
  • 电话:

    010-51322249;010-51322178(官网电话)

  • 邮箱:

    phc@cmaph.org(官网邮箱)

  • 复合因子:

    0

  • 综合因子:

    0

  • 收录:

    知网目次,万方目次,维普目次

  • 级别:

    国级普刊

期刊简介

《门静脉高压与肝硬化(英文)(Portal Hypertension & Cirrhosis)》期刊已被查看:

更新频次

单位占比

一作占比

/有基金-100.0%

投稿指南

1、投稿方式:在线投稿。

2、官网网址:

https://onlinelibrary.wiley.com/journal/27705846/

3、投稿系统:https://mc.manuscriptcentral.com/phc

4、期刊主页:

https://www.yiigle.com/Journal/Detail/206

5、官网电话:010-51322249;010-51322178

6、官网邮箱:phc@cmaph.org

7、出刊日期:季刊,逢季末月出版。

2024年4月17日星期三

《门静脉高压与肝硬化(英文)》作者指南

(Portal Hypertension & Cirrhosis)

【官网信息】

Author Guidelines

1. SUBMISSION

Thank you for your interest in Portal Hypertension & Cirrhosis (PH&C). Note that submission implies that the content has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium.

Free Format submission

Portal Hypertension & Cirrhosis (PH&C) now offers Free Format submission for a simplified and streamlined submission process.

Cover letter

A cover letter should be included in the ‘Cover Letter Field’ of the ScholarOne system. The text can be entered directly into the field or uploaded as a file.

The cover letter must contain:

i) A statement confirming the paper has not been published or submitted for publication elsewhere except as a brief abstract in the proceedings of a scientific meeting or symposium;

ii) An acknowledgment that all authors have contributed significantly and in keeping with the latest guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper is to be described, i.e., what role each author participated in;

iii) a statement confirming that all authors are in agreement with the content of the manuscript.

Submission

Once you have prepared your submission in accordance with the Guidelines, manuscripts should be submitted online at https://mc.manuscriptcentral.com/phc

We look forward to your submission.

2. AIMS AND SCOPE

Portal Hypertension & Cirrhosis (PH&C) is an open access, peer-reviewed journal that aims to publish cutting-edge academic advances on innovative achievements and practice in the field of portal hypertension and cirrhosis. The audience of the journal covers hepatologists, gastroenterologists, endoscopists, digestive surgeons, radiologists, oncologists, etc. PH&C is the official journal of Chinese Portal Hypertension Alliance (CHESS). This title is hosted by Chinese Medical Association (CMA), and supported by National Medical Center for Infectious Diseases of China.

3. MANUSCRIPT CATEGORIES AND REQUIREMENTS

(1) Editorial

Editorials are opinions or perspectives on the content of Portal Hypertension & Cirrhosis (PH&C) or of relevance to the field of portal hypertension or cirrhosis. Editorials are usually commissioned; however, unsolicited editorials are also welcome. Editorials can be up to 2000 words length with no more than 15 references.

Word Limit: 2,000 words maximum.

Abstract: not required.

Keywords: 3 to 10 keywords representing the main content of the article.

References: 15 maximum. If there are over 6 authors, please list at least 6 authors and et al.

Figures/tables: There should be maximum 1 figure or table.

List of abbreviations: If abbreviations are used in the abstract, text or figures/tables they should be defined in the abstract or text at first use and be defined in the figure legend or table notes.

……

更多详情:

https://onlinelibrary.wiley.com/page/journal/27705846/homepage/author-guidelines


中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。